While #Covid19 has impacted populations across the globe, it may have had an even greater effect on patients suffering from #rarediseases. The #pandemic has disrupted #orphandrugresearch, causing trial delays, site closures, and even program cancellations. On a positive note, by stimulating expanded acceptance and use of telehealth technologies, the Covid-19 pandemic may have rendered manufacturers’ […]
The post Understanding Rare Diseases and Orphan Drug Marketing (White Paper) appeared first on PharmaVOICE.
